nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—PSIP1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00831	1	CbGdCrCtD
L-DOPA—Masoprocol—CYP19A1—osteoporosis	0.00271	0.711	CrCbGaD
L-DOPA—Epinephrine—TNF—osteoporosis	0.0011	0.289	CrCbGaD
L-DOPA—Urticaria—Calcitriol—osteoporosis	0.000745	0.000907	CcSEcCtD
L-DOPA—Haemorrhage—Estradiol—osteoporosis	0.000743	0.000905	CcSEcCtD
L-DOPA—Palpitations—Zoledronate—osteoporosis	0.000742	0.000903	CcSEcCtD
L-DOPA—Abdominal pain—Calcitriol—osteoporosis	0.000741	0.000902	CcSEcCtD
L-DOPA—Hypoaesthesia—Estradiol—osteoporosis	0.00074	0.0009	CcSEcCtD
L-DOPA—Angioedema—Conjugated Estrogens—osteoporosis	0.000739	0.000899	CcSEcCtD
L-DOPA—Shock—Pamidronate—osteoporosis	0.000738	0.000899	CcSEcCtD
L-DOPA—Loss of consciousness—Zoledronate—osteoporosis	0.000738	0.000898	CcSEcCtD
L-DOPA—Hypersensitivity—Estropipate—osteoporosis	0.000736	0.000896	CcSEcCtD
L-DOPA—Thrombocytopenia—Pamidronate—osteoporosis	0.000735	0.000894	CcSEcCtD
L-DOPA—Urinary tract disorder—Estradiol—osteoporosis	0.000734	0.000894	CcSEcCtD
L-DOPA—Vomiting—Etidronic acid—osteoporosis	0.000734	0.000893	CcSEcCtD
L-DOPA—Cough—Zoledronate—osteoporosis	0.000733	0.000892	CcSEcCtD
L-DOPA—Urethral disorder—Estradiol—osteoporosis	0.000729	0.000887	CcSEcCtD
L-DOPA—Rash—Etidronic acid—osteoporosis	0.000728	0.000886	CcSEcCtD
L-DOPA—Convulsion—Zoledronate—osteoporosis	0.000728	0.000886	CcSEcCtD
L-DOPA—Dermatitis—Etidronic acid—osteoporosis	0.000727	0.000885	CcSEcCtD
L-DOPA—Hyperhidrosis—Pamidronate—osteoporosis	0.000725	0.000883	CcSEcCtD
L-DOPA—Syncope—Conjugated Estrogens—osteoporosis	0.000725	0.000883	CcSEcCtD
L-DOPA—Hypertension—Zoledronate—osteoporosis	0.000725	0.000882	CcSEcCtD
L-DOPA—Hypersensitivity—Alendronate—osteoporosis	0.000725	0.000882	CcSEcCtD
L-DOPA—Headache—Etidronic acid—osteoporosis	0.000723	0.00088	CcSEcCtD
L-DOPA—Asthenia—Estropipate—osteoporosis	0.000716	0.000872	CcSEcCtD
L-DOPA—Anorexia—Pamidronate—osteoporosis	0.000715	0.000871	CcSEcCtD
L-DOPA—Chest pain—Zoledronate—osteoporosis	0.000715	0.00087	CcSEcCtD
L-DOPA—Palpitations—Conjugated Estrogens—osteoporosis	0.000714	0.00087	CcSEcCtD
L-DOPA—Insomnia—Risedronate—osteoporosis	0.000714	0.000869	CcSEcCtD
L-DOPA—Anxiety—Zoledronate—osteoporosis	0.000712	0.000867	CcSEcCtD
L-DOPA—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000711	0.000865	CcSEcCtD
L-DOPA—Paraesthesia—Risedronate—osteoporosis	0.000709	0.000863	CcSEcCtD
L-DOPA—Pruritus—Estropipate—osteoporosis	0.000707	0.00086	CcSEcCtD
L-DOPA—Discomfort—Zoledronate—osteoporosis	0.000706	0.00086	CcSEcCtD
L-DOPA—Asthenia—Alendronate—osteoporosis	0.000706	0.000859	CcSEcCtD
L-DOPA—Hypersensitivity—Ibandronate—osteoporosis	0.000706	0.000859	CcSEcCtD
L-DOPA—Cough—Conjugated Estrogens—osteoporosis	0.000706	0.000859	CcSEcCtD
L-DOPA—Dyspnoea—Risedronate—osteoporosis	0.000704	0.000857	CcSEcCtD
L-DOPA—Hypotension—Pamidronate—osteoporosis	0.000701	0.000853	CcSEcCtD
L-DOPA—Convulsion—Conjugated Estrogens—osteoporosis	0.000701	0.000853	CcSEcCtD
L-DOPA—Dry mouth—Zoledronate—osteoporosis	0.000699	0.000851	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000699	0.000851	CcSEcCtD
L-DOPA—Fatigue—Ethinyl Estradiol—osteoporosis	0.000698	0.00085	CcSEcCtD
L-DOPA—Pruritus—Alendronate—osteoporosis	0.000696	0.000847	CcSEcCtD
L-DOPA—Dyspepsia—Risedronate—osteoporosis	0.000695	0.000846	CcSEcCtD
L-DOPA—Constipation—Ethinyl Estradiol—osteoporosis	0.000692	0.000843	CcSEcCtD
L-DOPA—Confusional state—Zoledronate—osteoporosis	0.000691	0.000841	CcSEcCtD
L-DOPA—Hypersensitivity—Calcitriol—osteoporosis	0.000691	0.000841	CcSEcCtD
L-DOPA—Flushing—Estradiol—osteoporosis	0.00069	0.00084	CcSEcCtD
L-DOPA—Chest pain—Conjugated Estrogens—osteoporosis	0.000688	0.000838	CcSEcCtD
L-DOPA—Asthenia—Ibandronate—osteoporosis	0.000687	0.000836	CcSEcCtD
L-DOPA—Anxiety—Conjugated Estrogens—osteoporosis	0.000686	0.000835	CcSEcCtD
L-DOPA—Nausea—Etidronic acid—osteoporosis	0.000686	0.000835	CcSEcCtD
L-DOPA—Oedema—Zoledronate—osteoporosis	0.000685	0.000834	CcSEcCtD
L-DOPA—Diarrhoea—Estropipate—osteoporosis	0.000683	0.000832	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Risedronate—osteoporosis	0.000681	0.000829	CcSEcCtD
L-DOPA—Fatigue—Risedronate—osteoporosis	0.00068	0.000828	CcSEcCtD
L-DOPA—Insomnia—Pamidronate—osteoporosis	0.000679	0.000826	CcSEcCtD
L-DOPA—Pruritus—Ibandronate—osteoporosis	0.000678	0.000825	CcSEcCtD
L-DOPA—Pain—Risedronate—osteoporosis	0.000675	0.000822	CcSEcCtD
L-DOPA—Constipation—Risedronate—osteoporosis	0.000675	0.000822	CcSEcCtD
L-DOPA—Shock—Zoledronate—osteoporosis	0.000674	0.000821	CcSEcCtD
L-DOPA—Paraesthesia—Pamidronate—osteoporosis	0.000674	0.00082	CcSEcCtD
L-DOPA—Diarrhoea—Alendronate—osteoporosis	0.000673	0.000819	CcSEcCtD
L-DOPA—Asthenia—Calcitriol—osteoporosis	0.000673	0.000819	CcSEcCtD
L-DOPA—Thrombocytopenia—Zoledronate—osteoporosis	0.000671	0.000817	CcSEcCtD
L-DOPA—Dyspnoea—Pamidronate—osteoporosis	0.000669	0.000814	CcSEcCtD
L-DOPA—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000667	0.000812	CcSEcCtD
L-DOPA—Somnolence—Pamidronate—osteoporosis	0.000667	0.000812	CcSEcCtD
L-DOPA—Pruritus—Calcitriol—osteoporosis	0.000663	0.000807	CcSEcCtD
L-DOPA—Hyperhidrosis—Zoledronate—osteoporosis	0.000662	0.000806	CcSEcCtD
L-DOPA—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000662	0.000806	CcSEcCtD
L-DOPA—Diarrhoea—Raloxifene—osteoporosis	0.000662	0.000806	CcSEcCtD
L-DOPA—Dyspepsia—Pamidronate—osteoporosis	0.00066	0.000804	CcSEcCtD
L-DOPA—Dizziness—Estropipate—osteoporosis	0.00066	0.000804	CcSEcCtD
L-DOPA—Oedema—Conjugated Estrogens—osteoporosis	0.00066	0.000803	CcSEcCtD
L-DOPA—Alopecia—Estradiol—osteoporosis	0.000657	0.0008	CcSEcCtD
L-DOPA—Diarrhoea—Ibandronate—osteoporosis	0.000655	0.000798	CcSEcCtD
L-DOPA—Anorexia—Zoledronate—osteoporosis	0.000653	0.000795	CcSEcCtD
L-DOPA—Decreased appetite—Pamidronate—osteoporosis	0.000652	0.000794	CcSEcCtD
L-DOPA—Mental disorder—Estradiol—osteoporosis	0.000651	0.000793	CcSEcCtD
L-DOPA—Dizziness—Alendronate—osteoporosis	0.00065	0.000792	CcSEcCtD
L-DOPA—Shock—Conjugated Estrogens—osteoporosis	0.000649	0.00079	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000648	0.000788	CcSEcCtD
L-DOPA—Fatigue—Pamidronate—osteoporosis	0.000647	0.000787	CcSEcCtD
L-DOPA—Gastrointestinal pain—Risedronate—osteoporosis	0.000645	0.000786	CcSEcCtD
L-DOPA—Urticaria—Ethinyl Estradiol—osteoporosis	0.000643	0.000783	CcSEcCtD
L-DOPA—Constipation—Pamidronate—osteoporosis	0.000642	0.000781	CcSEcCtD
L-DOPA—Pain—Pamidronate—osteoporosis	0.000642	0.000781	CcSEcCtD
L-DOPA—Diarrhoea—Calcitriol—osteoporosis	0.000641	0.000781	CcSEcCtD
L-DOPA—Hypotension—Zoledronate—osteoporosis	0.00064	0.000779	CcSEcCtD
L-DOPA—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00064	0.000779	CcSEcCtD
L-DOPA—Dizziness—Raloxifene—osteoporosis	0.00064	0.000779	CcSEcCtD
L-DOPA—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000638	0.000777	CcSEcCtD
L-DOPA—Flatulence—Estradiol—osteoporosis	0.000638	0.000776	CcSEcCtD
L-DOPA—Tension—Estradiol—osteoporosis	0.000635	0.000773	CcSEcCtD
L-DOPA—Vomiting—Estropipate—osteoporosis	0.000635	0.000773	CcSEcCtD
L-DOPA—Dysgeusia—Estradiol—osteoporosis	0.000634	0.000771	CcSEcCtD
L-DOPA—Dizziness—Ibandronate—osteoporosis	0.000633	0.000771	CcSEcCtD
L-DOPA—Rash—Estropipate—osteoporosis	0.00063	0.000766	CcSEcCtD
L-DOPA—Dermatitis—Estropipate—osteoporosis	0.000629	0.000766	CcSEcCtD
L-DOPA—Anorexia—Conjugated Estrogens—osteoporosis	0.000629	0.000766	CcSEcCtD
L-DOPA—Nervousness—Estradiol—osteoporosis	0.000628	0.000765	CcSEcCtD
L-DOPA—Urticaria—Risedronate—osteoporosis	0.000627	0.000763	CcSEcCtD
L-DOPA—Back pain—Estradiol—osteoporosis	0.000626	0.000762	CcSEcCtD
L-DOPA—Headache—Estropipate—osteoporosis	0.000626	0.000762	CcSEcCtD
L-DOPA—Vomiting—Alendronate—osteoporosis	0.000625	0.000761	CcSEcCtD
L-DOPA—Abdominal pain—Risedronate—osteoporosis	0.000624	0.000759	CcSEcCtD
L-DOPA—Muscle spasms—Estradiol—osteoporosis	0.000622	0.000757	CcSEcCtD
L-DOPA—Rash—Alendronate—osteoporosis	0.00062	0.000755	CcSEcCtD
L-DOPA—Insomnia—Zoledronate—osteoporosis	0.00062	0.000754	CcSEcCtD
L-DOPA—Dermatitis—Alendronate—osteoporosis	0.00062	0.000754	CcSEcCtD
L-DOPA—Feeling abnormal—Pamidronate—osteoporosis	0.000618	0.000753	CcSEcCtD
L-DOPA—Hypotension—Conjugated Estrogens—osteoporosis	0.000617	0.000751	CcSEcCtD
L-DOPA—Headache—Alendronate—osteoporosis	0.000616	0.00075	CcSEcCtD
L-DOPA—Paraesthesia—Zoledronate—osteoporosis	0.000615	0.000749	CcSEcCtD
L-DOPA—Vomiting—Raloxifene—osteoporosis	0.000615	0.000749	CcSEcCtD
L-DOPA—Gastrointestinal pain—Pamidronate—osteoporosis	0.000613	0.000747	CcSEcCtD
L-DOPA—Dyspnoea—Zoledronate—osteoporosis	0.000611	0.000744	CcSEcCtD
L-DOPA—Rash—Raloxifene—osteoporosis	0.00061	0.000742	CcSEcCtD
L-DOPA—Dermatitis—Raloxifene—osteoporosis	0.000609	0.000742	CcSEcCtD
L-DOPA—Somnolence—Zoledronate—osteoporosis	0.000609	0.000742	CcSEcCtD
L-DOPA—Vomiting—Ibandronate—osteoporosis	0.000609	0.000741	CcSEcCtD
L-DOPA—Tremor—Estradiol—osteoporosis	0.000606	0.000738	CcSEcCtD
L-DOPA—Headache—Raloxifene—osteoporosis	0.000606	0.000738	CcSEcCtD
L-DOPA—Rash—Ibandronate—osteoporosis	0.000604	0.000735	CcSEcCtD
L-DOPA—Dermatitis—Ibandronate—osteoporosis	0.000603	0.000734	CcSEcCtD
L-DOPA—Dyspepsia—Zoledronate—osteoporosis	0.000603	0.000734	CcSEcCtD
L-DOPA—Ill-defined disorder—Estradiol—osteoporosis	0.0006	0.000731	CcSEcCtD
L-DOPA—Headache—Ibandronate—osteoporosis	0.0006	0.00073	CcSEcCtD
L-DOPA—Insomnia—Conjugated Estrogens—osteoporosis	0.000597	0.000727	CcSEcCtD
L-DOPA—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000596	0.000726	CcSEcCtD
L-DOPA—Vomiting—Calcitriol—osteoporosis	0.000596	0.000726	CcSEcCtD
L-DOPA—Decreased appetite—Zoledronate—osteoporosis	0.000596	0.000725	CcSEcCtD
L-DOPA—Agitation—Estradiol—osteoporosis	0.000595	0.000724	CcSEcCtD
L-DOPA—Nausea—Estropipate—osteoporosis	0.000593	0.000722	CcSEcCtD
L-DOPA—Abdominal pain—Pamidronate—osteoporosis	0.000593	0.000722	CcSEcCtD
L-DOPA—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000593	0.000721	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000592	0.00072	CcSEcCtD
L-DOPA—Angioedema—Estradiol—osteoporosis	0.000591	0.00072	CcSEcCtD
L-DOPA—Rash—Calcitriol—osteoporosis	0.000591	0.00072	CcSEcCtD
L-DOPA—Fatigue—Zoledronate—osteoporosis	0.000591	0.000719	CcSEcCtD
L-DOPA—Dermatitis—Calcitriol—osteoporosis	0.000591	0.000719	CcSEcCtD
L-DOPA—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000588	0.000716	CcSEcCtD
L-DOPA—Headache—Calcitriol—osteoporosis	0.000587	0.000715	CcSEcCtD
L-DOPA—Somnolence—Conjugated Estrogens—osteoporosis	0.000587	0.000714	CcSEcCtD
L-DOPA—Constipation—Zoledronate—osteoporosis	0.000586	0.000713	CcSEcCtD
L-DOPA—Pain—Zoledronate—osteoporosis	0.000586	0.000713	CcSEcCtD
L-DOPA—Nausea—Alendronate—osteoporosis	0.000584	0.000711	CcSEcCtD
L-DOPA—Malaise—Estradiol—osteoporosis	0.000584	0.00071	CcSEcCtD
L-DOPA—Hypersensitivity—Risedronate—osteoporosis	0.000581	0.000708	CcSEcCtD
L-DOPA—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000581	0.000707	CcSEcCtD
L-DOPA—Asthenia—Ethinyl Estradiol—osteoporosis	0.000581	0.000707	CcSEcCtD
L-DOPA—Syncope—Estradiol—osteoporosis	0.00058	0.000706	CcSEcCtD
L-DOPA—Nausea—Raloxifene—osteoporosis	0.000575	0.000699	CcSEcCtD
L-DOPA—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000574	0.000698	CcSEcCtD
L-DOPA—Pruritus—Ethinyl Estradiol—osteoporosis	0.000573	0.000697	CcSEcCtD
L-DOPA—Palpitations—Estradiol—osteoporosis	0.000572	0.000696	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00057	0.000693	CcSEcCtD
L-DOPA—Fatigue—Conjugated Estrogens—osteoporosis	0.000569	0.000693	CcSEcCtD
L-DOPA—Nausea—Ibandronate—osteoporosis	0.000569	0.000692	CcSEcCtD
L-DOPA—Loss of consciousness—Estradiol—osteoporosis	0.000569	0.000692	CcSEcCtD
L-DOPA—Asthenia—Risedronate—osteoporosis	0.000566	0.000689	CcSEcCtD
L-DOPA—Feeling abnormal—Zoledronate—osteoporosis	0.000565	0.000687	CcSEcCtD
L-DOPA—Cough—Estradiol—osteoporosis	0.000565	0.000687	CcSEcCtD
L-DOPA—Constipation—Conjugated Estrogens—osteoporosis	0.000564	0.000687	CcSEcCtD
L-DOPA—Pain—Conjugated Estrogens—osteoporosis	0.000564	0.000687	CcSEcCtD
L-DOPA—Gastrointestinal pain—Zoledronate—osteoporosis	0.00056	0.000682	CcSEcCtD
L-DOPA—Hypertension—Estradiol—osteoporosis	0.000559	0.00068	CcSEcCtD
L-DOPA—Pruritus—Risedronate—osteoporosis	0.000558	0.00068	CcSEcCtD
L-DOPA—Nausea—Calcitriol—osteoporosis	0.000557	0.000678	CcSEcCtD
L-DOPA—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000554	0.000674	CcSEcCtD
L-DOPA—Hypersensitivity—Pamidronate—osteoporosis	0.000553	0.000673	CcSEcCtD
L-DOPA—Chest pain—Estradiol—osteoporosis	0.000551	0.000671	CcSEcCtD
L-DOPA—Anxiety—Estradiol—osteoporosis	0.000549	0.000668	CcSEcCtD
L-DOPA—Urticaria—Zoledronate—osteoporosis	0.000544	0.000663	CcSEcCtD
L-DOPA—Discomfort—Estradiol—osteoporosis	0.000544	0.000663	CcSEcCtD
L-DOPA—Abdominal pain—Zoledronate—osteoporosis	0.000542	0.000659	CcSEcCtD
L-DOPA—Diarrhoea—Risedronate—osteoporosis	0.00054	0.000657	CcSEcCtD
L-DOPA—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00054	0.000657	CcSEcCtD
L-DOPA—Dry mouth—Estradiol—osteoporosis	0.000539	0.000656	CcSEcCtD
L-DOPA—Asthenia—Pamidronate—osteoporosis	0.000538	0.000655	CcSEcCtD
L-DOPA—Dizziness—Ethinyl Estradiol—osteoporosis	0.000535	0.000652	CcSEcCtD
L-DOPA—Confusional state—Estradiol—osteoporosis	0.000532	0.000648	CcSEcCtD
L-DOPA—Pruritus—Pamidronate—osteoporosis	0.000531	0.000646	CcSEcCtD
L-DOPA—Oedema—Estradiol—osteoporosis	0.000528	0.000643	CcSEcCtD
L-DOPA—Urticaria—Conjugated Estrogens—osteoporosis	0.000524	0.000638	CcSEcCtD
L-DOPA—Dizziness—Risedronate—osteoporosis	0.000522	0.000635	CcSEcCtD
L-DOPA—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000522	0.000635	CcSEcCtD
L-DOPA—Shock—Estradiol—osteoporosis	0.00052	0.000632	CcSEcCtD
L-DOPA—Vomiting—Ethinyl Estradiol—osteoporosis	0.000515	0.000626	CcSEcCtD
L-DOPA—Diarrhoea—Pamidronate—osteoporosis	0.000513	0.000625	CcSEcCtD
L-DOPA—Hyperhidrosis—Estradiol—osteoporosis	0.000511	0.000621	CcSEcCtD
L-DOPA—Rash—Ethinyl Estradiol—osteoporosis	0.00051	0.000621	CcSEcCtD
L-DOPA—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00051	0.000621	CcSEcCtD
L-DOPA—Headache—Ethinyl Estradiol—osteoporosis	0.000507	0.000617	CcSEcCtD
L-DOPA—Hypersensitivity—Zoledronate—osteoporosis	0.000505	0.000615	CcSEcCtD
L-DOPA—Vomiting—Risedronate—osteoporosis	0.000502	0.000611	CcSEcCtD
L-DOPA—Rash—Risedronate—osteoporosis	0.000498	0.000606	CcSEcCtD
L-DOPA—Dermatitis—Risedronate—osteoporosis	0.000497	0.000605	CcSEcCtD
L-DOPA—Dizziness—Pamidronate—osteoporosis	0.000496	0.000604	CcSEcCtD
L-DOPA—Headache—Risedronate—osteoporosis	0.000494	0.000602	CcSEcCtD
L-DOPA—Asthenia—Zoledronate—osteoporosis	0.000492	0.000599	CcSEcCtD
L-DOPA—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000486	0.000592	CcSEcCtD
L-DOPA—Pruritus—Zoledronate—osteoporosis	0.000485	0.00059	CcSEcCtD
L-DOPA—Nausea—Ethinyl Estradiol—osteoporosis	0.000481	0.000585	CcSEcCtD
L-DOPA—Insomnia—Estradiol—osteoporosis	0.000478	0.000581	CcSEcCtD
L-DOPA—Vomiting—Pamidronate—osteoporosis	0.000477	0.000581	CcSEcCtD
L-DOPA—Paraesthesia—Estradiol—osteoporosis	0.000474	0.000577	CcSEcCtD
L-DOPA—Asthenia—Conjugated Estrogens—osteoporosis	0.000473	0.000576	CcSEcCtD
L-DOPA—Rash—Pamidronate—osteoporosis	0.000473	0.000576	CcSEcCtD
L-DOPA—Dermatitis—Pamidronate—osteoporosis	0.000473	0.000575	CcSEcCtD
L-DOPA—Dyspnoea—Estradiol—osteoporosis	0.000471	0.000573	CcSEcCtD
L-DOPA—Headache—Pamidronate—osteoporosis	0.00047	0.000572	CcSEcCtD
L-DOPA—Somnolence—Estradiol—osteoporosis	0.000469	0.000572	CcSEcCtD
L-DOPA—Diarrhoea—Zoledronate—osteoporosis	0.000469	0.000571	CcSEcCtD
L-DOPA—Nausea—Risedronate—osteoporosis	0.000469	0.000571	CcSEcCtD
L-DOPA—Pruritus—Conjugated Estrogens—osteoporosis	0.000467	0.000568	CcSEcCtD
L-DOPA—Dyspepsia—Estradiol—osteoporosis	0.000465	0.000566	CcSEcCtD
L-DOPA—Decreased appetite—Estradiol—osteoporosis	0.000459	0.000559	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Estradiol—osteoporosis	0.000456	0.000555	CcSEcCtD
L-DOPA—Fatigue—Estradiol—osteoporosis	0.000455	0.000554	CcSEcCtD
L-DOPA—Dizziness—Zoledronate—osteoporosis	0.000453	0.000552	CcSEcCtD
L-DOPA—Pain—Estradiol—osteoporosis	0.000452	0.00055	CcSEcCtD
L-DOPA—Constipation—Estradiol—osteoporosis	0.000452	0.00055	CcSEcCtD
L-DOPA—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000451	0.00055	CcSEcCtD
L-DOPA—Nausea—Pamidronate—osteoporosis	0.000446	0.000542	CcSEcCtD
L-DOPA—Dizziness—Conjugated Estrogens—osteoporosis	0.000436	0.000531	CcSEcCtD
L-DOPA—Vomiting—Zoledronate—osteoporosis	0.000436	0.00053	CcSEcCtD
L-DOPA—Feeling abnormal—Estradiol—osteoporosis	0.000435	0.00053	CcSEcCtD
L-DOPA—Rash—Zoledronate—osteoporosis	0.000432	0.000526	CcSEcCtD
L-DOPA—Gastrointestinal pain—Estradiol—osteoporosis	0.000432	0.000526	CcSEcCtD
L-DOPA—Dermatitis—Zoledronate—osteoporosis	0.000432	0.000525	CcSEcCtD
L-DOPA—Headache—Zoledronate—osteoporosis	0.000429	0.000523	CcSEcCtD
L-DOPA—Vomiting—Conjugated Estrogens—osteoporosis	0.00042	0.000511	CcSEcCtD
L-DOPA—Urticaria—Estradiol—osteoporosis	0.00042	0.000511	CcSEcCtD
L-DOPA—Abdominal pain—Estradiol—osteoporosis	0.000417	0.000508	CcSEcCtD
L-DOPA—Rash—Conjugated Estrogens—osteoporosis	0.000416	0.000506	CcSEcCtD
L-DOPA—Dermatitis—Conjugated Estrogens—osteoporosis	0.000416	0.000506	CcSEcCtD
L-DOPA—Headache—Conjugated Estrogens—osteoporosis	0.000413	0.000503	CcSEcCtD
L-DOPA—Nausea—Zoledronate—osteoporosis	0.000407	0.000496	CcSEcCtD
L-DOPA—Nausea—Conjugated Estrogens—osteoporosis	0.000392	0.000477	CcSEcCtD
L-DOPA—Hypersensitivity—Estradiol—osteoporosis	0.000389	0.000474	CcSEcCtD
L-DOPA—Asthenia—Estradiol—osteoporosis	0.000379	0.000461	CcSEcCtD
L-DOPA—Pruritus—Estradiol—osteoporosis	0.000374	0.000455	CcSEcCtD
L-DOPA—Diarrhoea—Estradiol—osteoporosis	0.000361	0.00044	CcSEcCtD
L-DOPA—Dizziness—Estradiol—osteoporosis	0.000349	0.000425	CcSEcCtD
L-DOPA—Vomiting—Estradiol—osteoporosis	0.000336	0.000409	CcSEcCtD
L-DOPA—Rash—Estradiol—osteoporosis	0.000333	0.000405	CcSEcCtD
L-DOPA—Dermatitis—Estradiol—osteoporosis	0.000333	0.000405	CcSEcCtD
L-DOPA—Headache—Estradiol—osteoporosis	0.000331	0.000403	CcSEcCtD
L-DOPA—Nausea—Estradiol—osteoporosis	0.000314	0.000382	CcSEcCtD
L-DOPA—DRD4—Signaling Pathways—LRP5—osteoporosis	0.000144	0.000864	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000143	0.00086	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CNR2—osteoporosis	0.000143	0.000858	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SOST—osteoporosis	0.000139	0.000838	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—POMC—osteoporosis	0.000138	0.000828	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LRP6—osteoporosis	0.000138	0.000827	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PTHLH—osteoporosis	0.000137	0.000821	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—WNT1—osteoporosis	0.000136	0.000818	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—P4HB—osteoporosis	0.000136	0.000816	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PTHLH—osteoporosis	0.000136	0.000814	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—WNT1—osteoporosis	0.000134	0.000807	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PTHLH—osteoporosis	0.000134	0.000803	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MGLL—osteoporosis	0.000133	0.000797	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CALCA—osteoporosis	0.000133	0.000796	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTH—osteoporosis	0.000132	0.000793	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MGLL—osteoporosis	0.000131	0.000787	CbGpPWpGaD
L-DOPA—PSIP1—Disease—MYC—osteoporosis	0.00013	0.000781	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—RAP1A—osteoporosis	0.00013	0.00078	CbGpPWpGaD
L-DOPA—PSIP1—Disease—TGFB1—osteoporosis	0.00013	0.00078	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LRP5—osteoporosis	0.000129	0.000778	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CNR2—osteoporosis	0.000129	0.000773	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LRP5—osteoporosis	0.000128	0.000768	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—ADCY5—osteoporosis	0.000128	0.000768	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CYP19A1—osteoporosis	0.000128	0.000767	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NFATC1—osteoporosis	0.000127	0.000761	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALCR—osteoporosis	0.000126	0.000758	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTH1R—osteoporosis	0.000126	0.000758	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DKK1—osteoporosis	0.000126	0.000755	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LRP6—osteoporosis	0.000124	0.000744	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PTH—osteoporosis	0.000123	0.000742	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PTHLH—osteoporosis	0.000123	0.00074	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—POMC—osteoporosis	0.000123	0.000737	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LRP6—osteoporosis	0.000122	0.000734	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PTHLH—osteoporosis	0.000121	0.00073	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—WNT1—osteoporosis	0.000121	0.000727	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CALCA—osteoporosis	0.00012	0.000723	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CNR2—osteoporosis	0.00012	0.000723	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CALCA—osteoporosis	0.000119	0.000717	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CALCA—osteoporosis	0.000118	0.000707	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FGA—osteoporosis	0.000118	0.000707	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TLN1—osteoporosis	0.000116	0.000698	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—ADCY5—osteoporosis	0.000116	0.000697	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PTH—osteoporosis	0.000112	0.000674	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—POMC—osteoporosis	0.00011	0.000664	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00011	0.000658	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTHLH—osteoporosis	0.000109	0.000657	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—BMP2—osteoporosis	0.000109	0.000657	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CNR2—osteoporosis	0.000109	0.000657	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—POMC—osteoporosis	0.000109	0.000655	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CALCA—osteoporosis	0.000108	0.000651	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FGB—osteoporosis	0.000107	0.000643	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CALCA—osteoporosis	0.000107	0.000642	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TLN1—osteoporosis	0.000105	0.000628	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ADCY5—osteoporosis	0.000104	0.000627	CbGpPWpGaD
L-DOPA—DDC—Metabolism—GPX1—osteoporosis	0.000104	0.000624	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PSMA5—osteoporosis	0.000103	0.000621	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PSMA2—osteoporosis	0.000103	0.000621	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TLN1—osteoporosis	0.000103	0.00062	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—POMC—osteoporosis	0.000103	0.00062	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—WNT1—osteoporosis	0.000103	0.000617	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PTHLH—osteoporosis	0.000102	0.000615	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—P4HB—osteoporosis	0.0001	0.000602	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MGLL—osteoporosis	0.0001	0.000602	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—IL6—osteoporosis	9.98e-05	0.0006	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LRP5—osteoporosis	9.78e-05	0.000588	CbGpPWpGaD
L-DOPA—PSIP1—Disease—IL6—osteoporosis	9.77e-05	0.000587	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTH—osteoporosis	9.74e-05	0.000586	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PKM—osteoporosis	9.73e-05	0.000585	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—FDPS—osteoporosis	9.73e-05	0.000585	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CALCA—osteoporosis	9.63e-05	0.000579	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MTHFR—osteoporosis	9.59e-05	0.000576	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RAP1A—osteoporosis	9.58e-05	0.000576	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CNR2—osteoporosis	9.5e-05	0.000571	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—ADCY5—osteoporosis	9.43e-05	0.000566	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—POMC—osteoporosis	9.39e-05	0.000565	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LRP6—osteoporosis	9.35e-05	0.000562	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NFATC1—osteoporosis	9.34e-05	0.000561	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PTHLH—osteoporosis	9.29e-05	0.000558	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DKK1—osteoporosis	9.27e-05	0.000557	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PGLS—osteoporosis	9.22e-05	0.000554	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GPD2—osteoporosis	9.22e-05	0.000554	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—P4HB—osteoporosis	9.02e-05	0.000542	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CALCA—osteoporosis	9.01e-05	0.000541	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—IL6—osteoporosis	8.98e-05	0.00054	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—WNT1—osteoporosis	8.93e-05	0.000537	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—P4HB—osteoporosis	8.9e-05	0.000535	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—IL6—osteoporosis	8.86e-05	0.000533	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTH—osteoporosis	8.77e-05	0.000527	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—KL—osteoporosis	8.75e-05	0.000526	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FGA—osteoporosis	8.69e-05	0.000522	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTH—osteoporosis	8.66e-05	0.00052	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RAP1A—osteoporosis	8.62e-05	0.000518	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—ADCY5—osteoporosis	8.56e-05	0.000514	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CNR2—osteoporosis	8.55e-05	0.000514	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—POMC—osteoporosis	8.53e-05	0.000513	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RAP1A—osteoporosis	8.51e-05	0.000511	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—ADCY5—osteoporosis	8.49e-05	0.00051	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CNR2—osteoporosis	8.44e-05	0.000507	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ATIC—osteoporosis	8.43e-05	0.000507	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PNP—osteoporosis	8.43e-05	0.000507	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NFATC1—osteoporosis	8.41e-05	0.000505	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—ADCY5—osteoporosis	8.37e-05	0.000503	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DKK1—osteoporosis	8.34e-05	0.000501	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—POMC—osteoporosis	8.34e-05	0.000501	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6R—osteoporosis	8.32e-05	0.0005	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NFATC1—osteoporosis	8.3e-05	0.000499	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DKK1—osteoporosis	8.23e-05	0.000495	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CALCA—osteoporosis	8.18e-05	0.000492	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTHLH—osteoporosis	8.07e-05	0.000485	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—BMP2—osteoporosis	8.07e-05	0.000485	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—WNT1—osteoporosis	8.04e-05	0.000483	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—WNT1—osteoporosis	7.93e-05	0.000477	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FGB—osteoporosis	7.9e-05	0.000475	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TLN1—osteoporosis	7.9e-05	0.000475	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FGA—osteoporosis	7.82e-05	0.00047	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FGA—osteoporosis	7.71e-05	0.000464	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—ADCY5—osteoporosis	7.71e-05	0.000463	CbGpPWpGaD
L-DOPA—DDC—Metabolism—POMC—osteoporosis	7.67e-05	0.000461	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PSMA5—osteoporosis	7.63e-05	0.000458	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PSMA2—osteoporosis	7.63e-05	0.000458	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—ADCY5—osteoporosis	7.6e-05	0.000457	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTHLH—osteoporosis	7.27e-05	0.000437	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—BMP2—osteoporosis	7.27e-05	0.000437	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTHLH—osteoporosis	7.17e-05	0.000431	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—BMP2—osteoporosis	7.17e-05	0.000431	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CA2—osteoporosis	7.17e-05	0.000431	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—OXCT1—osteoporosis	7.17e-05	0.000431	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FGB—osteoporosis	7.11e-05	0.000428	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CALCA—osteoporosis	7.11e-05	0.000427	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FGB—osteoporosis	7.02e-05	0.000422	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MGLL—osteoporosis	6.99e-05	0.00042	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—POMC—osteoporosis	6.93e-05	0.000417	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PSMA5—osteoporosis	6.87e-05	0.000413	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PSMA2—osteoporosis	6.87e-05	0.000413	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ADCY5—osteoporosis	6.85e-05	0.000412	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—P4HB—osteoporosis	6.81e-05	0.000409	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—osteoporosis	6.78e-05	0.000408	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PSMA2—osteoporosis	6.78e-05	0.000407	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PSMA5—osteoporosis	6.78e-05	0.000407	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SPP1—osteoporosis	6.63e-05	0.000398	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTH—osteoporosis	6.62e-05	0.000398	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RAP1A—osteoporosis	6.51e-05	0.000391	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—KL—osteoporosis	6.46e-05	0.000388	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CNR2—osteoporosis	6.45e-05	0.000388	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	6.41e-05	0.000385	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CALCA—osteoporosis	6.4e-05	0.000385	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NFATC1—osteoporosis	6.35e-05	0.000382	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CALCA—osteoporosis	6.31e-05	0.000379	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DKK1—osteoporosis	6.3e-05	0.000379	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—POMC—osteoporosis	6.3e-05	0.000378	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—POMC—osteoporosis	6.24e-05	0.000375	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—POMC—osteoporosis	6.16e-05	0.00037	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6R—osteoporosis	6.14e-05	0.000369	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—WNT1—osteoporosis	6.07e-05	0.000365	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IRS2—osteoporosis	5.99e-05	0.00036	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—IDH2—osteoporosis	5.94e-05	0.000357	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FGA—osteoporosis	5.9e-05	0.000355	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—LEP—osteoporosis	5.87e-05	0.000353	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ADCY5—osteoporosis	5.82e-05	0.00035	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—KL—osteoporosis	5.81e-05	0.000349	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—KL—osteoporosis	5.73e-05	0.000345	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—POMC—osteoporosis	5.67e-05	0.000341	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ESR1—osteoporosis	5.6e-05	0.000337	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—POMC—osteoporosis	5.59e-05	0.000336	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP27A1—osteoporosis	5.59e-05	0.000336	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6R—osteoporosis	5.53e-05	0.000332	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTHLH—osteoporosis	5.49e-05	0.00033	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—BMP2—osteoporosis	5.49e-05	0.00033	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6R—osteoporosis	5.46e-05	0.000328	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ACP5—osteoporosis	5.43e-05	0.000327	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FGB—osteoporosis	5.37e-05	0.000323	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IRS1—osteoporosis	5.23e-05	0.000314	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PSMA2—osteoporosis	5.18e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PSMA5—osteoporosis	5.18e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADCY5—osteoporosis	5.06e-05	0.000304	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TPI1—osteoporosis	5.05e-05	0.000304	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—POMC—osteoporosis	5.04e-05	0.000303	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6R—osteoporosis	4.92e-05	0.000295	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SPP1—osteoporosis	4.89e-05	0.000294	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IGF1—osteoporosis	4.85e-05	0.000291	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALCA—osteoporosis	4.83e-05	0.00029	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—P4HB—osteoporosis	4.75e-05	0.000285	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—POMC—osteoporosis	4.71e-05	0.000283	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GAPDH—osteoporosis	4.66e-05	0.00028	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADCY5—osteoporosis	4.55e-05	0.000274	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—RAP1A—osteoporosis	4.54e-05	0.000273	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADCY5—osteoporosis	4.49e-05	0.00027	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IRS2—osteoporosis	4.42e-05	0.000266	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SPP1—osteoporosis	4.4e-05	0.000265	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—KL—osteoporosis	4.39e-05	0.000264	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SPP1—osteoporosis	4.35e-05	0.000261	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LEP—osteoporosis	4.33e-05	0.00026	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—POMC—osteoporosis	4.28e-05	0.000257	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6R—osteoporosis	4.17e-05	0.000251	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ESR1—osteoporosis	4.13e-05	0.000248	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IRS2—osteoporosis	3.98e-05	0.000239	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IRS2—osteoporosis	3.93e-05	0.000236	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LEP—osteoporosis	3.9e-05	0.000234	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IRS1—osteoporosis	3.86e-05	0.000232	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LEP—osteoporosis	3.85e-05	0.000231	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ESR1—osteoporosis	3.72e-05	0.000224	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—osteoporosis	3.72e-05	0.000224	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—osteoporosis	3.71e-05	0.000223	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ESR1—osteoporosis	3.67e-05	0.000221	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ENO1—osteoporosis	3.67e-05	0.000221	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6R—osteoporosis	3.63e-05	0.000218	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PSMA5—osteoporosis	3.62e-05	0.000217	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PSMA2—osteoporosis	3.62e-05	0.000217	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF1—osteoporosis	3.58e-05	0.000215	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IRS1—osteoporosis	3.48e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADCY5—osteoporosis	3.44e-05	0.000207	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IRS1—osteoporosis	3.43e-05	0.000206	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—osteoporosis	3.35e-05	0.000201	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SPP1—osteoporosis	3.33e-05	0.0002	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—osteoporosis	3.3e-05	0.000199	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6R—osteoporosis	3.27e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6R—osteoporosis	3.22e-05	0.000194	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF1—osteoporosis	3.22e-05	0.000194	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF1—osteoporosis	3.18e-05	0.000191	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IRS2—osteoporosis	3.01e-05	0.000181	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LEP—osteoporosis	2.94e-05	0.000177	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP19A1—osteoporosis	2.93e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MYC—osteoporosis	2.91e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFB1—osteoporosis	2.91e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ESR1—osteoporosis	2.81e-05	0.000169	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—osteoporosis	2.74e-05	0.000164	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IRS1—osteoporosis	2.63e-05	0.000158	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—osteoporosis	2.53e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6R—osteoporosis	2.47e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—osteoporosis	2.46e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF1—osteoporosis	2.43e-05	0.000146	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—osteoporosis	2.43e-05	0.000146	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADCY5—osteoporosis	2.4e-05	0.000144	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GPX1—osteoporosis	2.39e-05	0.000144	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—osteoporosis	2.21e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—osteoporosis	2.19e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MYC—osteoporosis	2.15e-05	0.000129	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFB1—osteoporosis	2.14e-05	0.000129	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MYC—osteoporosis	1.94e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFB1—osteoporosis	1.93e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MYC—osteoporosis	1.91e-05	0.000115	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFB1—osteoporosis	1.91e-05	0.000114	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—osteoporosis	1.86e-05	0.000112	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—osteoporosis	1.76e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—osteoporosis	1.62e-05	9.71e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MYC—osteoporosis	1.46e-05	8.78e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFB1—osteoporosis	1.46e-05	8.76e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—osteoporosis	1.45e-05	8.74e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—osteoporosis	1.44e-05	8.63e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—osteoporosis	1.1e-05	6.6e-05	CbGpPWpGaD
